{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:49:16Z","timestamp":1789019356955,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jpba.2013.06.005","type":"journal-article","created":{"date-parts":[[2013,6,28]],"date-time":"2013-06-28T10:37:10Z","timestamp":1372415830000},"page":"73-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["An electrochemiluminescence (ECL)-based assay for the specific detection of anti-drug antibodies of the IgE isotype"],"prefix":"10.1016","volume":"86","author":[{"given":"Yuling","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorin K.","family":"Roskos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy I.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2013.06.005_bib0005","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2174\/138920108786786358","article-title":"Monoclonal antibodies as innovative therapeutics","volume":"9","author":"Reichert","year":"2008","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.jpba.2013.06.005_bib0010","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1164\/rccm.200312-1651OC","article-title":"Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma","volume":"170","author":"Djukanovi\u0107","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jpba.2013.06.005_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2008.01.001","article-title":"Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products","volume":"333","author":"Eugen","year":"2008","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jpba.2013.06.005_bib0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/15476910600908852","article-title":"Immunogenecity issues in drug development","volume":"3","author":"Swanson","year":"2006","journal-title":"J. Immunotoxicil."},{"key":"10.1016\/j.jpba.2013.06.005_bib0025","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/rheumatology\/kem261","article-title":"Monitoring patients treated with anti-TNF-alpha biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies","volume":"46","author":"Svenson","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jpba.2013.06.005_bib0030","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/ACI.0b013e3283464bcd","article-title":"Immediate adverse reactions to biologicals: from pathogenic mechanisms to prophylactic management","volume":"11","author":"Vultaggio","year":"2011","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.jpba.2013.06.005_bib0035","series-title":"Hypersensitivity Reactions and Detection Methods","author":"Marc","year":"2009"},{"key":"10.1016\/j.jpba.2013.06.005_bib0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaci.2009.11.031","article-title":"Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2009","volume":"125","author":"Sicherer","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jpba.2013.06.005_bib0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000087568","article-title":"Regulation of mast cell activation through FcepsilonRI","volume":"87","author":"Yamasaki","year":"2005","journal-title":"Chem. Immunol. Allergy"},{"key":"10.1016\/j.jpba.2013.06.005_bib0050","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.clinthera.2010.07.021","volume":"32","author":"Stubenrauch","year":"2010","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jpba.2013.06.005_bib0055","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jchromb.2010.01.036","article-title":"Identification and characterization of oxidation and deamidation sites in monoclonal rat\/mouse hybrid antibodies","volume":"878","author":"Timm","year":"2010","journal-title":"J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2013.06.005_bib0060","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jaci.2010.05.004","article-title":"Biological agents: new drugs, old problems","volume":"126","author":"Mu\u00f1oz-Cano","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jpba.2013.06.005_bib0065","first-page":"343","article-title":"Anaphylaxis and desensitization to the murine monoclonal antibody used for renal graft rejection","volume":"66","author":"Georgitis","year":"1991","journal-title":"Ann. Allergy"},{"key":"10.1016\/j.jpba.2013.06.005_bib0070","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMoa074943","article-title":"Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose","volume":"358","author":"Chung","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2013.06.005_bib0075","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S1471-4906(03)00142-X","article-title":"The Gell-Coombs classification of hypersensitivity reactions: a re-interpretation","volume":"7","author":"Rajan","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jpba.2013.06.005_bib0080","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0091-6749(95)70170-2","article-title":"In vitro detection of specific IgE antibodies to erythromycin","volume":"95","author":"Pascual","year":"1995","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jpba.2013.06.005_bib0085","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0091-6749(75)90005-6","article-title":"Measurement of IgE antibodies by the radioallergosorbent test, I. Technical considerations in the performance of the test","volume":"55","author":"Gleich","year":"1975","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jpba.2013.06.005_bib0090","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1398-9995.2009.02280.x","article-title":"Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions","volume":"65","author":"Vultaggio","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jpba.2013.06.005_bib0095","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jaci.2004.12.1131","article-title":"Quantitative measurement of IgE antibodies to purified allergens using streptavidin linked to a high-capacity solid phase","volume":"115","author":"Erwin","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jpba.2013.06.005_bib0100","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.cca.2012.02.018","article-title":"Specific IgE measurement using AdvanSure\u00ae system: comparison of detection performance with ImmunoCAP\u00ae system in Korean allergy patients","volume":"413","author":"Lee","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jpba.2013.06.005_bib0105","unstructured":"Design and validation of immunoassays for assessment of human allergenicity of new biotherapeutics drugs: approved guideline. Clin. and Lab. Standards Inst. I\/LA34-A, vol. 31, no. 12."},{"key":"10.1016\/j.jpba.2013.06.005_bib0110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/(SICI)1099-1352(199909\/10)12:5<279::AID-JMR473>3.0.CO;2-3","article-title":"Improving biosensor analysis","volume":"12","author":"Myszka","year":"1999","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.jpba.2013.06.005_bib0115","first-page":"329","article-title":"The next generation of antibody\u2013drug conjugates comes of age","volume":"10","author":"Beck","year":"2010","journal-title":"Discov. Med."},{"key":"10.1016\/j.jpba.2013.06.005_bib0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1586\/eci.10.90","article-title":"Acute infusion reactions induced by monoclonal antibody therapy","volume":"7","author":"Maggi","year":"2011","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jpba.2013.06.005_bib0125","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jaci.2009.09.009","article-title":"Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment","volume":"124","author":"Brennan","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jpba.2013.06.005_bib0130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1188\/10.CJON.E10-E21","article-title":"Infusion reactions: diagnosis, assessment, and management","volume":"14","author":"Vogel","year":"2010","journal-title":"Clin. J. Oncol. Nurs."},{"key":"10.1016\/j.jpba.2013.06.005_bib0135","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jpba.2009.03.002","article-title":"Tartrate-resistant acid phosphatase (TRACP 5b): a biomarker of bone resorption rate in support of drug development: modification, validation and application of the BoneTRAP kit assay","volume":"49","author":"Wu","year":"2009","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2013.06.005_bib0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jim.2010.02.008","article-title":"Identification and inhibition of drug target interference in immunogenicity assays","volume":"355","author":"Zhong","year":"2010","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jpba.2013.06.005_bib0145","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11882-005-0042-8","article-title":"A new paradigm for immunoglobulin E in allergic diseases","volume":"5","author":"Woodfolk","year":"2005","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.jpba.2013.06.005_bib0150","series-title":"Cancer and IgE, Introducing the Concept of AllergoOncology","first-page":"13","article-title":"The biology of IgE: molecular mechanism restraining potentially dangerous high serum IgE titres in vivo","author":"Achatz","year":"2010"},{"key":"10.1016\/j.jpba.2013.06.005_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2004.06.002","article-title":"Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products","volume":"289","author":"Mire-Sluis","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jpba.2013.06.005_bib0160","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jpba.2008.09.020","article-title":"Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products","volume":"48","author":"Shankar","year":"2008","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513002550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513002550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T19:27:26Z","timestamp":1539545246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708513002550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":32,"alternative-id":["S0731708513002550"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2013.06.005","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An electrochemiluminescence (ECL)-based assay for the specific detection of anti-drug antibodies of the IgE isotype","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2013.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}